{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:16:19Z","timestamp":1790644579419,"version":"4.1.0"},"reference-count":80,"publisher":"The Endocrine Society","issue":"10","license":[{"start":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T00:00:00Z","timestamp":1623628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Myotonic dystrophy is a dominantly inherited multisystem disorder that results from increased CTG repeats in the 3\u2032 region of the myotonic dystrophy protein kinase gene (DMPK). The mutant DMPK mRNA remains in the nucleus and sequesters RNA-binding proteins, including regulators of mRNA splicing. Myotonic dystrophy is characterized by a highly variable phenotype that includes muscle weakness and myotonia, and the disorder may affect the function of many endocrine glands. DMPK mRNA is expressed in muscle, testis, liver, pituitary, thyroid, and bone; the mutated form leads to disruption of meiosis and an increase in fetal insulin receptor-A relative to adult insulin receptor-B, resulting in adult primary testicular failure and insulin resistance predisposing to diabetes, respectively. Patients with myotonic dystrophy are also at increased risk for hyperlipidemia, nonalcoholic fatty liver disease, erectile dysfunction, benign and malignant thyroid nodules, bone fractures, miscarriage, preterm delivery, and failed labor during delivery. Circulating parathyroid hormone and adrenocorticotropic hormone levels may be elevated, but the mechanisms for these associations are unclear. This review summarizes what is known about endocrine dysfunction in individuals with myotonic dystrophy.<\/jats:p>","DOI":"10.1210\/clinem\/dgab430","type":"journal-article","created":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T15:58:53Z","timestamp":1623686333000},"page":"2819-2827","source":"Crossref","is-referenced-by-count":22,"title":["Endocrine Dysfunction in Patients With Myotonic Dystrophy"],"prefix":"10.1210","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3721-7388","authenticated-orcid":false,"given":"Stephen J","family":"Winters","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Metabolism and Diabetes, University of Louisville, Louisville, KY 40202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2021,6,14]]},"reference":[{"issue":"13","key":"2021110612090839600_CIT0001","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1136\/hrt.2010.214197","article-title":"Mechanisms and management of the heart in myotonic dystrophy","volume":"97","author":"McNally","year":"2011","journal-title":"Heart."},{"issue":"5","key":"2021110612090839600_CIT0002","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/WCO.0000000000000128","article-title":"Myotonic dystrophy: diagnosis, management and new therapies","volume":"27","author":"Turner","year":"2014","journal-title":"Curr Opin Neurol."},{"issue":"3","key":"2021110612090839600_CIT0003","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ncl.2014.04.011","article-title":"Myotonic dystrophy","volume":"32","author":"Thornton","year":"2014","journal-title":"Neurol Clin."},{"issue":"6","key":"2021110612090839600_CIT0004","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/mus.26716","article-title":"Clinical and genetic characteristics of childhood-onset myotonic dystrophy","volume":"60","author":"Stokes","year":"2019","journal-title":"Muscle Nerve."},{"key":"2021110612090839600_CIT0005","doi-asserted-by":"crossref","first-page":"R162","DOI":"10.1093\/hmg\/ddl181","article-title":"RNA-dominant diseases","volume":"15 Spec No 2","author":"Osborne","year":"2006","journal-title":"Hum Mol Genet."},{"issue":"1","key":"2021110612090839600_CIT0006","first-page":"114","article-title":"Somatic heterogeneity of the CTG repeat in myotonic dystrophy is age and size dependent","volume":"56","author":"Wong","year":"1995","journal-title":"Am J Hum Genet."},{"issue":"5","key":"2021110612090839600_CIT0007","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1468-1331.2002.00453.x","article-title":"Myotonic dystrophy type 2","volume":"9","author":"Finsterer","year":"2002","journal-title":"Eur J Neurol."},{"issue":"4","key":"2021110612090839600_CIT0008","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s10072-016-2805-5","article-title":"Myotonic dystrophy type 2 and modifier genes: an update on clinical and pathomolecular aspects","volume":"38","author":"Meola","year":"2017","journal-title":"Neurol Sci."},{"issue":"2","key":"2021110612090839600_CIT0009","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bbadis.2006.05.013","article-title":"Myotonic dystrophy: emerging mechanisms for DM1 and DM2","volume":"1772","author":"Cho","year":"2007","journal-title":"Biochim Biophys Acta."},{"issue":"9","key":"2021110612090839600_CIT0010","doi-asserted-by":"crossref","DOI":"10.3390\/genes11091109","article-title":"An overview of alternative splicing defects implicated in myotonic dystrophy type I","volume":"11","author":"L\u00f3pez-Mart\u00ednez","year":"2020","journal-title":"Genes (Basel)."},{"issue":"1","key":"2021110612090839600_CIT0011","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/ene.12542","article-title":"Endocrine function over time in patients with myotonic dystrophy type 1","volume":"22","author":"Dahlqvist","year":"2015","journal-title":"Eur J Neurol."},{"issue":"8-9","key":"2021110612090839600_CIT0012","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.nmd.2004.03.012","article-title":"In situ hybridization analysis of Dmpk mRNA in adult mouse tissues","volume":"14","author":"Sarkar","year":"2004","journal-title":"Neuromuscul Disord."},{"issue":"2","key":"2021110612090839600_CIT0013","first-page":"142","article-title":"Myotonic dystrophy presenting as male infertility: a case report","volume":"32","author":"Futterweit","year":"1987","journal-title":"Int J Fertil."},{"issue":"2","key":"2021110612090839600_CIT0014","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4111\/kju.2012.53.2.134","article-title":"Myotonic dystrophy type 1 presenting as male infertility","volume":"53","author":"Kim","year":"2012","journal-title":"Korean J Urol."},{"key":"2021110612090839600_CIT0015","first-page":"735868","article-title":"Primary hyperparathyroidism and hyperthyroidism in a patient with myotonic dystrophy: a case report and review of the literature","volume":"2015","author":"Cherif","year":"2015","journal-title":"Case Rep Endocrinol."},{"key":"2021110612090839600_CIT0016","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/1756-0500-6-243","article-title":"Myotonic dystrophy type 1 presenting with stroke-like episodes: a case report","volume":"6","author":"Rollnik","year":"2013","journal-title":"BMC Res Notes."},{"key":"2021110612090839600_CIT0017","article-title":"Myotonic dystrophy type 1 with diabetes mellitus, mixed hypogonadism and adrenal insufficiency","volume":"2018","author":"Takeshima","year":"2018","journal-title":"Endocrinol Diabetes Metab Case Rep."},{"issue":"9","key":"2021110612090839600_CIT0018","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4254\/wjh.v12.i9.685","article-title":"Non-alcoholic fatty liver disease later diagnosed as myotonic dystrophy","volume":"12","author":"Tanaka","year":"2020","journal-title":"World J Hepatol."},{"issue":"76","key":"2021110612090839600_CIT0019","first-page":"303","article-title":"Dystrophia myotonica: an endocrine study","volume":"19","author":"Caughey","year":"1950","journal-title":"Q J Med."},{"issue":"5","key":"2021110612090839600_CIT0020","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/BF03350681","article-title":"Hypothalamic-pituitary-testicular function in 70 patients with myotonic dystrophy","volume":"13","author":"Vazquez","year":"1990","journal-title":"J Endocrinol Invest."},{"issue":"2","key":"2021110612090839600_CIT0021","first-page":"106","article-title":"Hypogonadism and erectile dysfunction in myotonic dystrophy type 1","volume":"32","author":"Peric","year":"2013","journal-title":"Acta Myol."},{"issue":"2","key":"2021110612090839600_CIT0022","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1530\/acta.0.0840382","article-title":"Pituitary-gonadal function in male patients with myotonic dystrophy- serum luteinizing hormone, follicle stimulating hormone and testosterone levels and histological dmaage of the testis","volume":"84","author":"Takeda","year":"1977","journal-title":"Acta Endocrinol (Copenh)."},{"issue":"1","key":"2021110612090839600_CIT0023","first-page":"72","article-title":"Dystrophia, myotonica-a metabolic study","volume":"70","author":"Martin","year":"1954","journal-title":"Can Med Assoc J."},{"issue":"7","key":"2021110612090839600_CIT0024","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/eci.12459","article-title":"Gonadal failure is associated with visceral adiposity in myotonic dystrophies","volume":"45","author":"Passeri","year":"2015","journal-title":"Eur J Clin Invest."},{"issue":"4","key":"2021110612090839600_CIT0025","first-page":"199","article-title":"Study of anti-M\u00fcllerian hormone levels in patients with Myotonic Dystrophy Type 1. Preliminary results","volume":"36","author":"Ergoli","year":"2017","journal-title":"Acta Myol."},{"issue":"6","key":"2021110612090839600_CIT0026","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1210\/jcem-35-6-852","article-title":"Gonadal function in males with myotonic dystrophy","volume":"35","author":"Harper","year":"1972","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2021110612090839600_CIT0027","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF03349005","article-title":"Male hypogonadism in myotonic dystrophy is related to (CTG)n triplet mutation","volume":"17","author":"Mastrogiacomo","year":"1994","journal-title":"J Endocrinol Invest."},{"issue":"1","key":"2021110612090839600_CIT0028","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/mrd.23307","article-title":"Study of expression of genes potentially responsible for reduced fitness in patients with myotonic dystrophy type 1 and identification of new biomarkers of testicular function","volume":"87","author":"Ergoli","year":"2020","journal-title":"Mol Reprod Dev."},{"issue":"3","key":"2021110612090839600_CIT0029","article-title":"CTG expansion in the DMPK gene: semen quality assessment and outcome of preimplantation genetic diagnosis","volume":"105","author":"Puy","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"2021110612090839600_CIT0030","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/archneur.1985.04060080063017","article-title":"Lack of relationship of hypogonadism to muscle wasting in myotonic dystrophy","volume":"42","author":"Griggs","year":"1985","journal-title":"Arch Neurol."},{"issue":"2 Pt 1","key":"2021110612090839600_CIT0031","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1212\/WNL.39.2.219","article-title":"Randomized controlled trial of testosterone in myotonic dystrophy","volume":"39","author":"Griggs","year":"1989","journal-title":"Neurology."},{"issue":"6","key":"2021110612090839600_CIT0032","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.celrep.2013.05.031","article-title":"Cellular source and mechanisms of high transcriptome complexity in the mammalian testis","volume":"3","author":"Soumillon","year":"2013","journal-title":"Cell Rep."},{"issue":"4","key":"2021110612090839600_CIT0033","doi-asserted-by":"crossref","first-page":"e1526","DOI":"10.1002\/wrna.1526","article-title":"Tissue-specific mechanisms of alternative polyadenylation: Testis, brain, and beyond (2018 update)","volume":"10","author":"MacDonald","year":"2019","journal-title":"Wiley Interdiscip Rev RNA."},{"issue":"1","key":"2021110612090839600_CIT0034","doi-asserted-by":"crossref","first-page":"38","DOI":"10.7150\/ijbs.34422","article-title":"The function of Pre-mRNA alternative splicing in mammal spermatogenesis","volume":"16","author":"Song","year":"2020","journal-title":"Int J Biol Sci."},{"issue":"4","key":"2021110612090839600_CIT0035","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4103\/1008-682X.151397","article-title":"RNA binding proteins in spermatogenesis: an in depth focus on the Musashi family","volume":"17","author":"Sutherland","year":"2015","journal-title":"Asian J Androl."},{"issue":"22","key":"2021110612090839600_CIT0036","doi-asserted-by":"crossref","first-page":"10170","DOI":"10.1093\/nar\/gkt811","article-title":"The splicing landscape is globally reprogrammed during male meiosis","volume":"41","author":"Schmid","year":"2013","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"2021110612090839600_CIT0037","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1128\/MCB.01009-06","article-title":"Inactivation of CUG-BP1\/CELF1 causes growth, viability, and spermatogenesis defects in mice","volume":"27","author":"Kress","year":"2007","journal-title":"Mol Cell Biol."},{"issue":"10","key":"2021110612090839600_CIT0038","doi-asserted-by":"crossref","first-page":"e46337","DOI":"10.1371\/journal.pone.0046337","article-title":"Inactivation of the Celf1 gene that encodes an RNA-binding protein delays the first wave of spermatogenesis in mice","volume":"7","author":"Cibois","year":"2012","journal-title":"Plos One."},{"issue":"3","key":"2021110612090839600_CIT0039","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1055\/s-2004-831893","article-title":"Inhibins in normal male physiology","volume":"22","author":"O\u2019Connor","year":"2004","journal-title":"Semin Reprod Med."},{"issue":"2","key":"2021110612090839600_CIT0040","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/andr.12459","article-title":"Leydig cell insufficiency in hypospermatogenesis: a paracrine effect of activin-inhibin signaling?","volume":"6","author":"Winters","year":"2018","journal-title":"Andrology."},{"issue":"5","key":"2021110612090839600_CIT0041","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1210\/er.2017-00073","article-title":"Insulin receptor isoforms in physiology and disease: an updated view","volume":"38","author":"Belfiore","year":"2017","journal-title":"Endocr Rev."},{"issue":"6","key":"2021110612090839600_CIT0042","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/humrep\/17.6.1578","article-title":"Increased (CTG\/CAG)(n) lengths in myotonic dystrophy type 1 and Machado-Joseph disease genes in idiopathic azoospermia patients","volume":"17","author":"Pan","year":"2002","journal-title":"Hum Reprod."},{"issue":"5","key":"2021110612090839600_CIT0043","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1399-0004.1992.tb03247.x","article-title":"Fertility in myotonic dystrophy in Saguenay-Lac-St-Jean: a historical perspective","volume":"42","author":"Dao","year":"1992","journal-title":"Clin Genet."},{"issue":"1","key":"2021110612090839600_CIT0044","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.rbmo.2014.03.013","article-title":"Ovarian reserve and PGD treatment outcome in women with myotonic dystrophy","volume":"29","author":"Srebnik","year":"2014","journal-title":"Reprod Biomed Online."},{"issue":"2","key":"2021110612090839600_CIT0045","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejogrb.2012.02.020","article-title":"Pregnancy course and outcome in women with hereditary neuromuscular disorders: comparison of obstetric risks in 178 patients","volume":"162","author":"Awater","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"issue":"4","key":"2021110612090839600_CIT0046","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1586\/14737175.2.4.561","article-title":"Genetic prenatal and preimplantation diagnosis of trinucleotide repeat disorders","volume":"2","author":"Dean","year":"2002","journal-title":"Expert Rev Neurother."},{"issue":"2","key":"2021110612090839600_CIT0047","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1086\/422762","article-title":"Intergenerational instability of the expanded CTG repeat in the DMPK gene: studies in human gametes and preimplantation embryos","volume":"75","author":"De Temmerman","year":"2004","journal-title":"Am J Hum Genet."},{"issue":"12","key":"2021110612090839600_CIT0048","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1002\/1097-4598(200012)23:12<1789::AID-MUS2>3.0.CO;2-4","article-title":"Clinical and genetic heterogeneity in myotonic dystrophies","volume":"23","author":"Meola","year":"2000","journal-title":"Muscle Nerve."},{"issue":"4","key":"2021110612090839600_CIT0049","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1172\/JCI109198","article-title":"Decreased insulin sensitivity of forearm muscle in myotonic dystrophy","volume":"62","author":"Moxley","year":"1978","journal-title":"J Clin Invest."},{"issue":"2","key":"2021110612090839600_CIT0050","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ana.410150208","article-title":"Whole body insulin resistance in myotonic dystrophy","volume":"15","author":"Moxley","year":"1984","journal-title":"Ann Neurol."},{"issue":"5","key":"2021110612090839600_CIT0051","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1210\/jcem-29-5-684","article-title":"Studies of plasma insulin in myotonic dystrophy","volume":"29","author":"Gordon","year":"1969","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2021110612090839600_CIT0052","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/mus.24540","article-title":"Metabolic syndrome in patients with myotonic dystrophy type 1","volume":"52","author":"Vujnic","year":"2015","journal-title":"Muscle Nerve."},{"issue":"2","key":"2021110612090839600_CIT0053","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1600-0404.2009.01237.x","article-title":"Leptin and the metabolic syndrome in patients with myotonic dystrophy type 1","volume":"121","author":"Rakocevic Stojanovic","year":"2010","journal-title":"Acta Neurol Scand."},{"issue":"2","key":"2021110612090839600_CIT0054","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/ajcn\/80.2.357","article-title":"Postabsorptive and insulin-stimulated energy and protein metabolism in patients with myotonic dystrophy type 1","volume":"80","author":"Perseghin","year":"2004","journal-title":"Am J Clin Nutr."},{"issue":"1","key":"2021110612090839600_CIT0055","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.nmd.2019.11.006","article-title":"Fragility fractures and bone mineral density in male patients affected by type 1 and type 2 myotonic dystrophy","volume":"30","author":"Passeri","year":"2020","journal-title":"Neuromuscul Disord."},{"issue":"5","key":"2021110612090839600_CIT0056","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s10072-019-03763-0","article-title":"Body composition analysis in patients with myotonic dystrophy types 1 and 2","volume":"40","author":"Peric","year":"2019","journal-title":"Neurol Sci."},{"issue":"2","key":"2021110612090839600_CIT0057","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/mus.21484","article-title":"Frequency and predictors of nonalcoholic fatty liver disease in myotonic dystrophy","volume":"41","author":"Shieh","year":"2010","journal-title":"Muscle Nerve."},{"key":"2021110612090839600_CIT0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.dld.2020.12.010","article-title":"Clinical characteristics of metabolic associated fatty liver disease (MAFLD) in subjects with myotonic dystrophy type 1 (DM1)","author":"Miele","year":"2021","journal-title":"Dig Liver Dis."},{"issue":"1","key":"2021110612090839600_CIT0059","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ng704","article-title":"Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy","volume":"29","author":"Savkur","year":"2001","journal-title":"Nat Genet."},{"issue":"1-2","key":"2021110612090839600_CIT0060","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11010-013-1681-z","article-title":"Alternative splicing of human insulin receptor gene (INSR) in type I and type II skeletal muscle fibers of patients with myotonic dystrophy type 1 and type 2","volume":"380","author":"Santoro","year":"2013","journal-title":"Mol Cell Biochem."},{"issue":"9","key":"2021110612090839600_CIT0061","doi-asserted-by":"crossref","first-page":"e0184987","DOI":"10.1371\/journal.pone.0184987","article-title":"Receptor and post-receptor abnormalities contribute to insulin resistance in myotonic dystrophy type 1 and type 2 skeletal muscle","volume":"12","author":"Renna","year":"2017","journal-title":"Plos One."},{"issue":"10","key":"2021110612090839600_CIT0062","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1093\/brain\/awy231","article-title":"Improved mobility with metformin in patients with myotonic dystrophy type 1: a randomized controlled trial","volume":"141","author":"Bassez","year":"2018","journal-title":"Brain."},{"issue":"9","key":"2021110612090839600_CIT0063","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1007\/s00415-013-6984-1","article-title":"Vitamin D deficiency in myotonic dystrophy type 1","volume":"260","author":"Terracciano","year":"2013","journal-title":"J Neurol."},{"issue":"5","key":"2021110612090839600_CIT0064","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1007\/s00415-011-6277-5","article-title":"Endocrine function in 97 patients with myotonic dystrophy type 1","volume":"259","author":"\u00d8rngreen","year":"2012","journal-title":"J Neurol."},{"issue":"11","key":"2021110612090839600_CIT0065","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1111\/imj.14307","article-title":"Dysregulation of calcium metabolism in type 1 myotonic dystrophy","volume":"49","author":"Hlaing","year":"2019","journal-title":"Intern Med J."},{"issue":"10","key":"2021110612090839600_CIT0066","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s004150050155","article-title":"Abnormal calcium metabolism in myotonic dystrophy as shown by the Ellsworth-Howard test and its relation to CTG triplet repeat length","volume":"244","author":"Kinoshita","year":"1997","journal-title":"J Neurol."},{"issue":"3","key":"2021110612090839600_CIT0067","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1210\/jcem-67-3-488","article-title":"Hyperparathyroidism in patients with myotonic dystrophy","volume":"67","author":"Yoshida","year":"1988","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2021110612090839600_CIT0068","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0022-510X(85)90175-3","article-title":"Evaluation of renal parathyroid hormone receptor function in myotonic dystrophy","volume":"70","author":"Konagaya","year":"1985","journal-title":"J Neurol Sci."},{"issue":"10","key":"2021110612090839600_CIT0069","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/bph.13490","article-title":"Relaxin and insulin-like peptide 3 in the musculoskeletal system: from bench to bedside","volume":"174","author":"Ferlin","year":"2017","journal-title":"Br J Pharmacol."},{"issue":"2","key":"2021110612090839600_CIT0070","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00198-013-2442-2","article-title":"Risk of fracture in patients with muscular dystrophies","volume":"25","author":"Pouwels","year":"2014","journal-title":"Osteoporos Int."},{"issue":"3","key":"2021110612090839600_CIT0071","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.nmd.2017.12.010","article-title":"Falls and resulting fractures in Myotonic Dystrophy: Results from a multinational retrospective survey","volume":"28","author":"Jim\u00e9nez-Moreno","year":"2018","journal-title":"Neuromuscul Disord."},{"issue":"3","key":"2021110612090839600_CIT0072","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0022-510X(79)90015-7","article-title":"Myotonic dystrophy associated with thyroid disease","volume":"43","author":"Rioperez","year":"1979","journal-title":"J Neurol Sci."},{"issue":"1","key":"2021110612090839600_CIT0073","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13023-019-1019-3","article-title":"Systematic thyroid screening in myotonic dystrophy: link between thyroid volume and insulin resistance","volume":"14","author":"Ben Hamou","year":"2019","journal-title":"Orphanet J Rare Dis."},{"issue":"8","key":"2021110612090839600_CIT0074","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/acn3.50856","article-title":"Benign tumors in myotonic dystrophy type I target disease-related cancer sites","volume":"6","author":"Alsaggaf","year":"2019","journal-title":"Ann Clin Transl Neurol."},{"issue":"2","key":"2021110612090839600_CIT0075","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.mayocp.2011.09.005","article-title":"Increased cancer risks in myotonic dystrophy","volume":"87","author":"Win","year":"2012","journal-title":"Mayo Clin Proc."},{"issue":"1","key":"2021110612090839600_CIT0076","first-page":"179","article-title":"Adrenocorticotropin hyperresponse to the corticotropin-releasing hormone-mediated stimulus of naloxone in patients with myotonic dystrophy","volume":"80","author":"Grice","year":"1995","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2021110612090839600_CIT0077","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.4158\/ACCR-2018-0382","article-title":"Rare POMC mutation in a patient with myotonic dystrophy type 1 and adrenocorticotropin hyperresponse to corticotropin-releasing hormone","volume":"5","author":"Cantara","year":"2019","journal-title":"AACE Clin Case Rep."},{"issue":"3","key":"2021110612090839600_CIT0078","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1210\/jcem-60-3-611","article-title":"Reduced adrenal androgens in patients with myotonic dystrophy","volume":"60","author":"Carter","year":"1985","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"2021110612090839600_CIT0079","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1210\/jcem.86.9.7865","article-title":"Glucocorticoid metabolism and adrenocortical reactivity to ACTH in myotonic dystrophy","volume":"86","author":"Johansson","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2021110612090839600_CIT0080","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11154-008-9092-2","article-title":"Adrenal changes associated with adrenarche","volume":"10","author":"Nakamura","year":"2009","journal-title":"Rev Endocr Metab Disord."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgab430\/38873030\/dgab430.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/10\/2819\/41098111\/dgab430.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/10\/2819\/41098111\/dgab430.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T12:10:52Z","timestamp":1636200652000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/106\/10\/2819\/6298576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,14]]},"references-count":80,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,6,14]]},"published-print":{"date-parts":[[2021,9,27]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgab430","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2021,6,14]]}}}